7-ethyl-10-hydroxycamptothecin
7-ethyl-10-hydroxycamptothecin
7-ethyl-10-hydroxycamptothecin pro medio Irinotecani adhibetur .
Irinotecan antitumor medicamento.Inhibitor est synthesis DNA.Est semi- derivativum syntheticum camptothecin;Usus ad hydrochloridem irinotecanum et irinotecan hydrochloride trihydratum parandum;Magnae scalae clinicae probationes ostenderunt hydrochloridem irinotecanum effectus inhibitores manifestos habere in variis tumoribus, sicut cancer colon, parva cellula pulmonis cancri, cancer rectalis et leukemia, et adhuc efficax in causis fluorouracil repugnantibus.Ergo, irinotecan hydrochloridum in toto orbe terrarum maximam attentionem advertit.
JIN DUN Medical hasISO absolute et occurrat GMP productionis signapharmacum domesticum et alienum synthesin peritis copiosa experientia ad ducendam societatem R&D.
TECHNOL OGY COMMODUS
● Maximum Pressure Catalytic Hydrogenation .High Pressure Hydrogenolysis Reactio.Cryogenic Reactio (<-78%C)
Aromatica Heterocyclica Synthesis
Rearrangement reactionem
Chiral Consilium
● Heck, Suzuki, Negishi, Sonogashira .Gignardus Reactio
Apparatus
Lab noster varias habet experimentales et tentationes armorum, ut: NMR (Bruker 400M) 、HPLC、chiral-HPLC、LC-MS、LC-MS/MS (API 4000) 、IR、UV、GC、GC-MS, Chromatographia Proin Synthesizer, Parallel Synthesizer, Differentialis ENARRATIO Calorimeter (DSC), Electron Microscopium...
R&D Team
Medicus Jindun coetus professionales R&D habet, et multos peritos domesticos et externos medicamentorum synthesis ad ducendos R&D adhibet, nostram synthesim accuratiorem et efficientem reddit.
Plures societates pharmaceuticae domesticae supremae adiuverunt, utHansoh, Hengrui et HEC Pharm.Pars eorum hic ostendemus.
Customzation Case One:
Cas No.: 110351-94-5
Customzation Case Duo:
Cas No.: 144848-24-8
Casus Consuetudinis Tres:
Cas No.: 200636-54-0
1.Customize nova media vel APIs.Eadem quae supra in casu communicantes, clientes postulationes habent pro certis Intermediis vel APIs, et emendas necessarias in foro invenire non possunt, tunc ad Mos adiuvare possumus.
2.Processus Optimization ad Vetus Products.Manipulus noster adiuvabit ad Optimize et meliorem talem productionem cuius via reactionem est vetus, sumptus productio alta est et efficientia humilis est.Plena documenta praebere possumus pro technologia translationis ac processu meliorationis, emptoris auxilio ad efficaciorem productionem.
Ex scutis medicamento ad INDs, JIN DUN Medical te cumunus-subsisto personalized R&D solutiones.
JIN DUN Medicus instat in somniis creandis bigam, productos graves, anxios, severos faciendos, omnesque exitum esse fidelem socium ac amicum clientium!
![6-tetra-O-acteyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofu-ran-3-yl]oxy]phenyl]](http://cdn.globalso.com/jindunchem-med/0ecf55f0-300x300.jpg)
